Gyrification abnormalities in presymptomatic c9orf72 expansion carriers

被引:24
|
作者
Caverzasi, Eduardo [1 ]
Battistella, Giovanni [1 ]
Chu, Stephanie A. [2 ]
Rosen, Howie [2 ]
Zanto, Theodore P. [1 ]
Karydas, Anna [1 ]
Shwe, Wendy [2 ]
Coppola, Giovanni [3 ]
Geschwind, Daniel H. [4 ]
Rademakers, Rosa [5 ]
Miller, Bruce L. [2 ,6 ]
Gorno-Tempini, Maria Luisa [2 ]
Lee, Suzee E. [1 ]
机构
[1] Univ Calif San Francisco, Neurol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Neurol Memory & Aging Ctr, San Francisco, CA 94143 USA
[3] Univ Calif Los Angeles, Neurol, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Psychiat & Neurol, Los Angeles, CA 90024 USA
[5] Mayo Clin, Coll Med, Neurosci, Jacksonville, FL 32224 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源
基金
美国国家卫生研究院;
关键词
HEXANUCLEOTIDE REPEAT EXPANSION; SURFACE-BASED ANALYSIS; FRONTOTEMPORAL DEMENTIA; CORTICAL GYRIFICATION; CONNECTIVITY; ADOLESCENTS; DISORDER; CHILDREN; ATROPHY; AREA;
D O I
10.1136/jnnp-2018-320265
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective To investigate in-vivo cortical gyrification patterns measured by the local gyrification index (lGI) in presymptomatic c9orf72 expansion carriers compared with healthy controls, and investigate relationships between lGI and cortical thickness, an established morphometric measure of neurodegeneration. Methods We assessed cortical gyrification and thickness patterns in a cohort of 15 presymptomatic c9orf72 expansion carriers (age 43.7 +/- 10.2 years, 9 females) compared with 67 (age 42.4 +/- 12.4 years, 36 females) age and sex matched healthy controls using the dedicated Freesurfer pipeline. Results Compared with controls, presymptomatic carriers showed significantly lower lGI in left frontal and right parieto-occipital regions. Interestingly, those areas with abnormal gyrification in presymptomatic carriers showed no concomitant cortical thickness abnormality. Overall, for both presymptomatic carriers and healthy controls, gyrification and cortical thickness measures were not correlated, suggesting that gyrification captures a feature distinct from cortical thickness. Conclusions Presymptomatic c9orf72 expansion carriers show regions of abnormally low gyrification as early as their 30s, decades before expected symptom onset. Cortical gyrification represents a novel grey matter metric distinctive from grey matter thickness or volume and detects differences in presymptomatic carriers at an early age.
引用
收藏
页码:1005 / 1010
页数:6
相关论文
共 50 条
  • [21] Longitudinal changes in resting state networks in early presymptomatic carriers of C9orf72 expansions
    Shoukry, Rachel Smallwood
    Waugh, Rebecca
    Bartlett, Dan
    Raitcheva, Denitza
    Floeter, Mary Kay
    NEUROIMAGE-CLINICAL, 2020, 28
  • [22] The Phenotype of the C9ORF72 Expansion Carriers According to Revised Criteria for bvFTD
    Solje, Eino
    Aaltokallio, Heidi
    Koivumaa-Honkanen, Heli
    Suhonen, Noora M.
    Moilanen, Virpi
    Kiviharju, Anna
    Traynor, Bryan
    Tienari, Pentti J.
    Hartikainen, Paivi
    Remes, Anne M.
    PLOS ONE, 2015, 10 (07):
  • [23] A small deletion in C9orf72 hides a proportion of expansion carriers in FTLD
    Rollinson, Sara
    Callister, Janis Bennion
    Young, Kate
    Ryan, Sarah J.
    Druyeh, Ronald
    Rohrer, Jonathan D.
    Snowden, Julie
    Richardson, Anna
    Jones, Matt
    Harris, Jenny
    Davidson, Yvonne
    Robinson, Andrew
    Ealing, John
    Johnson, Janel O.
    Traynor, Bryan
    Mead, Simon
    Mann, David
    Pickering-Brown, Stuart M.
    NEUROBIOLOGY OF AGING, 2015, 36 (03) : 1601.e1 - e5
  • [24] Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers
    Finch, NiCole A.
    Wang, Xue
    Baker, Matthew C.
    Heckman, Michael G.
    Gendron, Tania F.
    Bieniek, Kevin F.
    Wuu, Joanne
    DeJesus-Hernandez, Mariely
    Brown, Patricia H.
    Chew, Jeannie
    Jansen-West, Karen R.
    Daughrity, Lillian M.
    Nicholson, Alexandra M.
    Murray, Melissa E.
    Josephs, Keith A.
    Parisi, Joseph E.
    Knopman, David S.
    Petersen, Ronald C.
    Petrucelli, Leonard
    Boeve, Bradley F.
    Graff-Radford, Neill R.
    Asmann, Yan W.
    Dickson, Dennis W.
    Benatar, Michael
    Bowser, Robert
    Boylan, Kevin B.
    Rademakers, Rosa
    van Blitterswijk, Marka
    NEUROLOGY-GENETICS, 2017, 3 (04)
  • [25] Epigenetic profile in FTLD patients C9ORF72 repeat expansion carriers
    Piaceri, I.
    Lombardi, G.
    Tedde, A.
    Ferrari, C.
    Bagnoli, S.
    Bessi, V.
    Nacmias, B.
    Sorbi, S.
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 52 : S2 - S3
  • [26] Neuroimaging features of C9ORF72 expansion
    Jennifer S Yokoyama
    Howard J Rosen
    Alzheimer's Research & Therapy, 4
  • [27] Brain morphologic changes in asymptomatic C9orf72 repeat expansion carriers
    Walhout, Renee
    Schmidt, Ruben
    Westeneng, Henk-Jan
    Verstraete, Esther
    Seelen, Meinie
    van Rheenen, Wouter
    de Reus, Marcel A.
    van Es, Michael A.
    Hendrikse, Jeroen
    Veldink, Jan H.
    van den Heuvel, Martijn P.
    van den Berg, Leonard H.
    NEUROLOGY, 2015, 85 (20) : 1780 - 1788
  • [28] Neuroimaging features of C9ORF72 expansion
    Yokoyama, Jennifer S.
    Rosen, Howard J.
    ALZHEIMERS RESEARCH & THERAPY, 2012, 4 (06):
  • [29] Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology
    Beer, Alexander M.
    Cooper-Knock, Johnathan
    Higginbottom, Adrian
    Highley, J. Robin
    Wharton, Stephen B.
    Ince, Paul G.
    Milano, Antonio
    Jones, Ashley A.
    Al-Chalabi, Ammar
    Kirby, Janine
    Shaw, Pamela J.
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2015, 16 (3-4) : 249 - 251
  • [30] Disease progression in C9orf72 mutation carriers
    Floeter, Mary K.
    Traynor, Bryan J.
    Farren, Jennifer
    Braun, Laura E.
    Tierney, Michael
    Wiggs, Edythe A.
    Wu, Tianxia
    NEUROLOGY, 2017, 89 (03) : 234 - 241